Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,245 total articles
Flex sits at the intersection of contract manufacturing, regulated medical assembly and cloud/power infrastructure hardware. With partnerships to localize AI server manufacturing and a solid free cash flow base, the stock looks set to capture durable AI supply-chain demand. This trade idea lays out an actionable long with entry, stop and target, a …
Arista (ANET) sold off hard after earnings, but the company's position in AI data-center networking, durable free cash flow, and a large backlog make this a compelling long-term trade. This idea lays out an entry at $155.00, a $200.00 target over 180 trading days, and a $139.00 stop — balancing upside from AI-related demand with margin and supply r…
Nuvation Bio (NUVB) is a clinical-stage oncology biotech transitioning to commercialization with the Ibtrozi launch. The market is pricing in execution risk after recent investor lawsuits and insider sales, but the balance sheet, improving technical picture, and a concentrated short interest create a high-reward opportunity. This trade targets a me…
Broadcom reported a blowout quarter driven by AI chips and software, yet shares dropped sharply on guidance nuance. The sell-off looks like an overreaction. I initiated a long position at $398.64 with a $475 target and a $360 stop, targeting a re-rate as AI revenue momentum and locked-in cloud demand prove durable over the next 180 trading days.
Ciena beat recent estimates and raised guidance, but the stock's multiple and weakening technicals suggest the market has priced in too much. Enter a tactical short near $488.14 with a tight stop above recent intraday highs and a multi-step target to capture a de-rating as AI capex sentiment normalizes.
ServiceNow (NOW) pulled back into the low $110s after a broad SaaS sell-off. Fundamentals remain intact: $115.99B market cap, $4.63B in free cash flow, ROE ~15% and low leverage. Short-term sentiment swung negative then reversed around early June; that momentum reset creates an attractive long entry at $113.00 with a $145.00 target and $98.00 stop.…
Alvotech (ALVO) is a speculative buy here. The stock trades near $3.64 with a market cap of roughly $1.11B after an FDA complete response letter tied to a facility inspection sent the narrative into the red. The company still has five marketed biosimilars, nine development-stage candidates and enough commercial progress to make a recovery plausible…
Shopify is a market leader in commerce infrastructure with strong cash generation and a newly increased $5B buyback program. Valuation is full today, so I plan to accumulate at the $94 52-week low with a $150 target and an $86 stop. The trade balances a long-term conviction in platform growth with disciplined risk control.
Broadcom (AVGO) has pulled back sharply, but beneath the headline volatility the company retains durable secular advantages, strong free cash flow, and enterprise exposure that should support a recovery. This is a tactical long trade that aims to capture mean reversion into value and upcoming catalysts while keeping position risk-defined.
T-Mobile is executing a capital-efficient expansion into broadband while maintaining wireless subscriber momentum. With market cap near $193B, free cash flow of $18.2B and valuation metrics that look reasonable for the growth profile, a tactical long with a defined stop and clear catalysts offers an asymmetric reward-to-risk.
Airbnb is showing the kind of margin expansion investors have long waited for while demand metrics remain healthy. The stock trades near its moving averages, offering a defined risk-reward for a mid-term swing trade as bookings and profitability improve. We outline an actionable entry, stop and target and the catalysts that could push shares toward…
Nano Labs (NA) is a Hangzhou-based fabless chip and distributed computing play that has quietly pivoted into AI infrastructure and crypto reserves. The stock is trading at a sub-$50M market cap with low valuation multiples, heavy short interest and recent product and partnership news. This trade idea outlines a mid-term swing entry with concrete pr…
Innovative Industrial Properties (IIPR) yields ~13% at $58.50 while recent tenant recoveries, a $88.5M asset sale with $49M seller financing at 15% and a conservative balance sheet materially reduce tail risk. The market appears slow to re-price the stock. We outline a mid-term swing trade with defined entry, stop and target and explain why dividen…
Centerra Gold (CGAU) has repriced lower into a valuation that looks inconsistent with its asset base and recent earnings power. With a market cap of roughly $3.03B, a P/E near 4.9 and three producing operations including Mount Milligan - a permitted, scalable copper-gold mine - the risk/reward favors a long position. This trade plan targets a recov…
enGene (ENGN) has plunged from a $12.25 peak to under $2. The balance sheet is thin and the company burns cash, but the stock is deeply oversold (RSI 28.5) and trading at a sub-0.4 P/B with an enterprise value below $100M. For traders willing to accept biotech binary risk, a disciplined long with a tight stop and a clear time horizon can offer asym…
Inspire Medical Systems has been punished unfairly by guidance uncertainty and litigation headlines. At ~$41.21 the shares trade at ~9x reported earnings with an enterprise value near $1.09B and free cash flow of roughly $97M. For active traders willing to take a medium risk, a disciplined long into $41.21 with a stop at $36.00 and a target of $58.…
Atour (ATAT) trades below recent highs after a pullback. The company is executing rapid hotel expansion, posted double-digit revenue growth, and just reinforced shareholder returns via dividends and buybacks. A tactical long entry around $33.00 offers an asymmetric risk/reward to $40.00 with a $31.00 stop on a mid-term (45 trading days) horizon.
Rent the Runway (RENT) offers a high-risk, asymmetric trade today: the business is growing (Q1 revenue +29% YoY to $89.9m and 155,692 active subscribers), the market cap is tiny (~$112m) and valuation multiples are depressed (P/S 0.32, EV/Sales 0.66). Headwinds - lower gross margins, negative cash flow and leadership change - are real. This idea tr…
Lockheed Martin is a high-quality defense franchise trading at a reasonable multiple given its cash generation, dividend yield (≈2.6%), and program-backed revenue visibility. This trade targets a sector-led re-rating and continued program execution rather than speculative space hype.
Amcor combines a chunky dividend (yield ~6.8%) with steady free cash flow and reasonable valuation metrics (EV/EBITDA ~9.5). The shares have pulled back toward the low of the year while the packaging addressable markets — from sustainable flexible films to pharmaceutical packaging — remain structurally solid. This trade idea buys a yield cushion an…
Regeneron combines durable cash generation from marketed biologics with expanding optionality from two sizable collaboration programs. The stock trades at roughly $635 with a P/E near 15 and free cash flow north of $4.1B - valuation that looks reasonable given pipeline optionality backed by meaningful upfronts and milestone potential. We recommend …
Green Dot has been beaten down by deal-related noise and delayed filings, but the underlying business is cash-generative, trading below book and cheap on sales. This trade idea targets a re-rating as the company pivots from legacy prepaid into scaled BaaS and money-movement services.
Nature's Sunshine (NATR) looks like a classic fundamentals-plus-technical setup: healthy cash flow, no net debt, and clear digital initiatives collide with oversold technicals and rising short interest. We lay out a mid-term trade plan that aims to capture a re-rating back toward prior moving averages while protecting capital on a failure below rec…
Ambev (ABEV) looks like a practical long on weakness. The stock is trading near $3.12 with a healthy 6.6% yield, a mid-teens P/E and recent signs of margin resilience. Technicals are neutral-to-mildly-bearish, so this is a disciplined, medium-risk swing where the reward is income plus upside to the 52-week high.
Enact Holdings' profitable mortgage insurance business continues to generate cash, return capital and underpin Enact Holdings' valuation. Recent dividend increase, a fresh $500M repurchase authorization and an A- rating for Enact Re give a tangible framework for upside. Technicals are neutral; use a disciplined entry and stop to capture upside towa…
